Activated charcoal: Difference between revisions

(Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template))
(Switch SMW query from broadtable to table format for better layout with TOC)
 
(One intermediate revision by the same user not shown)
Line 97: Line 97:
  |?Has Route=Route
  |?Has Route=Route
  |?Has Population=Population
  |?Has Population=Population
  |format=broadtable
  |format=table
  |headers=plain
  |headers=plain
  |link=subject
  |mainlabel=-
  |sort=Has Indication
  |sort=Has Indication
  |limit=50
  |limit=50

Latest revision as of 21:55, 20 March 2026

General

A micrograph of activated charcoal showing fractal-like shape of the particles that provides an enormous surface area. Each particle in this image, despite being only around 0.1 mm across, can have a surface area of several square centimeters.
  • Type: Antidote
  • A fine, black, odorless powder recognized for more than 2 centuries as an effective adsorbent of many substances
  • Common Trade Names: Actidose-Aqua [OTC]; Actidose/Sorbitol [OTC]; Char-Flo with Sorbitol [OTC]; EZ Char [OTC]; Kerr Insta-Char in Sorbitol [OTC]; Kerr Insta-Char [OTC] [1]

Adult Dosing

  • 25-100gm PO[2]
  • Common standard dose is 50gm
  • 10:1 ratio of charcoal to xenobiotic typically recommended
  • If not pre-mixed best administered in a 1:8 ratio of AC to liquid (water, coke)
  • AC alone comparably effective to AC to cathartic (sorbitol, Mg citrate)
    • if cathartic is used, it should only be a single time (avoid in multidose activated charcoal therapy)
    • repeated dosages associated with dehydration, hypotension, electrolyte derangements

Pediatric Dosing

  • 0.5-1 gm/kg PO[2]

Special Populations

Indications

  • Should be considered for a poisoned or overdosed patient after risk-to-benefit assessment of the ingested substance and patient-specific factors
  • Ingested drug is adsorbed by charcoal AND one of the following:
    • Time since ingestion is less than 1-2hr
    • Drug has significant enterohepatic circulation
    • Drug delays gastric emptying AND time since ingestion is <4hr
    • Drug is a controlled release preparation AND time since ingestion is <12-18hr

THE KILLER CS

  • Cyanide
  • Colchicine
  • Calcium channel blockers
  • Cyclic antidepressants
  • Cardioglycosides
  • Cyclopeptide mushrooms (Amanita phalloides)
  • Cocaine
  • Cicutoxin (water hemlock)
  • Salicylates

AACT recommendations

  • Activated charcoal "should not be administered routinely in the management of poisoned patients."[2]
  • Consider if patient presents within one hour of an ingestion of a toxic amount of a substance known to be absorbed by charcoal
    • Administration of charcoal after an hour may continue to be beneficial
  • They emphasize that there is no definitive data that activated charcoal improves clinical outcome

Contraindications

  • Altered mental status
  • Intestinal obstruction
  • Increased risk of aspiration
  • Ingestion of substances not absorbed by charcoal
  • Instances where urgent endoscopy will be needed (eg. Ingestion of caustic material)

Limitations

Adverse Reactions

Pharmacology

  • Half-life: not absorbed
  • Metabolism: not absorbed
  • Excretion: excreted whole in feces
  • Adsorption begins within about 1 minute but may not achieve equilibrium for 10-25 minutes
  • Clinical efficacy inversely related to time elapsed after ingestion and depends on rate of adsorption of xenobiotic

Mechanism of action

  • Large surface area of the charcoal binds toxins and prevents their absorption
  • Interrupts enteroenteric/enterohepatic circulation of drugs[3]

Comments

  • Created by heating wood and other natural materials in an airless environment
  • "Activated" by turning into fine powder, which ↑ surface area


Indications by Condition

The following table is automatically generated from disease/condition pages across WikEM.


See Also

References

  1. Activated Charcoal. online.lexi.com.elibrary.einstein.yu.edu/lco/action/doc/retrieve/docid/patch_f/6579?hl=5864#f_pregnancy-and-lactation. Updated 10/5/15. Accessed 12/30/15.
  2. 2.0 2.1 2.2 Chyka PA, Seger D, Krenzelok EP, Vale JA; American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. Position paper: Single-dose activated charcoal. Clin Toxicol (Phila). 2005;43(2):61-87.
  3. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol. 1999;37(6):731-51.